NCT00165464
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer No drug interventions treatment 2 completed NCT02085564
Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer No drug interventions Not Available Not Available completed NCT05480384
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction No drug interventions treatment 2 recruiting NCT01774851
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach treatment 2 terminated NCT01813253
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer treatment 3 terminated NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT05322577
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. basic_science 1 recruiting NCT04276493
Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab treatment 1 / 2 active_not_recruiting NCT06411171
Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer: treatment 3 not_yet_recruiting NCT02661971
FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) treatment 2 / 3 completed NCT01747707
Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer treatment 2 unknown_status NCT02178956
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer treatment 3 completed NCT04510285
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection treatment 2 terminated NCT06532006
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer treatment 3 not_yet_recruiting NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 treatment 2 recruiting NCT05447234
TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy No drug interventions treatment 0 not_yet_recruiting NCT02872116
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer treatment 3 completed NCT03448835
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) treatment 2 unknown_status NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06558786
Registry for Esophageal and Gastroesophageal Junction Cancer No drug interventions Not Available Not Available recruiting NCT05539430
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma No drug interventions treatment 1 recruiting NCT02027948
A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer No drug interventions other Not Available completed NCT03925974
KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer treatment 2 completed NCT03221426
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) treatment 3 active_not_recruiting NCT03529266
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma. treatment 2 completed NCT01576666
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors other 1 completed NCT01743365
Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer treatment 2 completed NCT05187182
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer treatment 1 recruiting NCT05494060
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma treatment 2 recruiting NCT06217991
A Clinical Study of Laparoscopic Proximal Gastrectomy Based on PTST(Parachute-tunnel- Style Technique) Esophagogastric Anastomose. No drug interventions treatment Not Available enrolling_by_invitation NCT02581462
FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer treatment 2 / 3 completed NCT02538562
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea No drug interventions Not Available Not Available completed NCT05395780
A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer treatment 2 unknown_status NCT04520867
STRENGTH Expansion No drug interventions Not Available Not Available withdrawn NCT06585501
A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China No drug interventions Not Available Not Available enrolling_by_invitation NCT02501603
Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer treatment 2 completed NCT04082364
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer treatment 2 / 3 active_not_recruiting NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04396821
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04931654
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer treatment 1 / 2 recruiting NCT06101277
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) No drug interventions treatment Not Available recruiting NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT06499298
Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer Not Available Not Available not_yet_recruiting NCT04061928
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ treatment 1 / 2 unknown_status NCT05439993
Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma treatment 1 / 2 recruiting NCT05608785
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes treatment 1 / 2 not_yet_recruiting NCT06121700
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer treatment 2 recruiting NCT02726399
Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer treatment 2 terminated NCT05233436
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors treatment 1 terminated NCT06447636
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma treatment 2 not_yet_recruiting NCT03941873
A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) or Gastric/Gastroesophageal Junction Cancer (GC/GEJC) treatment 1 / 2 completed NCT03847168
KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer No drug interventions treatment 1 unknown_status NCT04882241
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension treatment 3 active_not_recruiting NCT06093425
Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma treatment 3 not_yet_recruiting NCT05687357
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma treatment 2 recruiting NCT01748773
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer treatment 2 completed NCT06250894
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction No drug interventions treatment 2 recruiting NCT00917462
Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer treatment 2 completed NCT06452329
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer Not Available Not Available active_not_recruiting NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 treatment 3 recruiting NCT03488667
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma treatment 2 active_not_recruiting NCT02433301
PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy No drug interventions Not Available Not Available completed NCT05872295
IKS014 in Advanced Solid Tumors That Express HER2 No drug interventions treatment 1 recruiting NCT03957564
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer No drug interventions treatment 2 unknown_status NCT03829345
A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer treatment 2 unknown_status NCT01457846
Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer No drug interventions treatment 2 terminated NCT05009966
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor No drug interventions treatment 1 unknown_status NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies treatment 1 recruiting NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05894824
An Open Label, Single-arm, Multicenter Phase Ib/II Study to Evaluate the Safety and Efficacy of T-Dxd in Combination With Ramucirumab as a 2nd Line in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma treatment 1 / 2 not_yet_recruiting NCT06005493
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01077999
Chemoradiation and Panitumumab for Esophageal Cancer treatment 2 completed NCT00716157
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation No drug interventions Not Available Not Available completed NCT02359968
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer treatment 2 completed NCT05053295
Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer No drug interventions treatment Not Available unknown_status NCT00215514
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma prevention 0 completed NCT01044511
Quality of Life With Esophageal Stent Trial No drug interventions supportive_care Not Available unknown_status NCT01084330
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer treatment 2 completed NCT04847466
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer treatment 2 recruiting NCT01248403
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy No drug interventions treatment 3 completed NCT02988921
MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy No drug interventions diagnostic Not Available recruiting NCT03139487
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism treatment 2 unknown_status NCT03211377
Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma No drug interventions Not Available Not Available unknown_status NCT04821778
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer treatment 3 recruiting NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT04752358
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) No drug interventions treatment 2 terminated NCT05245760
ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer treatment 2 withdrawn NCT04821843
Neoadjuvant Treatment Modalities in Esophageal Cancer treatment 3 recruiting NCT06310473
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial treatment 2 not_yet_recruiting NCT02979691
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 No drug interventions treatment 2 / 3 completed NCT05275062
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma No drug interventions treatment 0 unknown_status NCT04675138
Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care No drug interventions Not Available Not Available recruiting NCT02999295
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer No drug interventions treatment 1 / 2 completed NCT00780494
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma treatment 2 completed NCT00800969
Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach No drug interventions diagnostic 2 withdrawn NCT03505320
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer treatment 2 recruiting NCT03528629
A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma treatment Not Available completed NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers treatment 1 recruiting